Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease

被引：0

作者：

Malo de Molina, Rosa ^{[1
]}

Restrepo, Marcos I. ^{[2
,3
]}

Mortensen, Eric M. ^{[2
,4
]}

Izquierdo, Jose L. ^{[5
]}

Anzueto, Antonio ^{[2
,3
]}

机构：

[1] Hosp Univ Puerta Hierro Majadahonda, Dept Pulm Med, Madrid, Spain

[2] South Texas Vet Hlth Care Syst, VERDICT Res Unit, San Antonio, TX USA

[3] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Dept Pulm & Crit Care Med, San Antonio, TX USA

[4] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Gen Internal Med, San Antonio, TX USA

[5] Hosp Univ Guadalajara, Dept Pulm Med, Guadalajara, Spain

来源：

CURRENT RESPIRATORY MEDICINE REVIEWS | 2010年 / 6卷 / 03期

关键词：

Chronic obstructive pulmonary disease; pneumonia; inhaled corticosteroids;

D O I：

10.2174/157339810791526229

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

Inhaled corticosteroids (ICS) have been recommended for use in patients with chronic obstructive pulmonary disease (COPD) in order to decrease exacerbation rates and improve health related quality of life parameters. Nevertheless, recent studies have reported an increased risk of pneumonia associated with this treatment. However, most studies were not specifically designed to detect pneumonia as a possible secondary effect and for this reason it is difficult to determine whether this risk exists and assess its magnitude. This paper reviews the published studies reporting pneumonia events in COPD patients treated with ICS.

引用

页码：162 / 166

页数：5

共 50 条

[41] Tuberculosis, chronic obstructive pulmonary disease and inhaled corticosteroids: a complex web
Allwood, B. W.
van Zyl-Smit, R.
[J]. INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2017, 21 (12) : 1317 - 1318
[42] Extent of Overuse of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease Reply
Rinne, Seppo T.
Wiener, Renda Soylemez
Chen, Yahong
Rise, Peter
Udris, Edmunds
Feemster, Laura C.
Au, David H.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199 (02) : 249 - 250
[43] Cost-effectiveness of inhaled corticosteroids in chronic obstructive pulmonary disease
Lee, TA
Weiss, KB
Sullivan, SD
[J]. AMERICAN JOURNAL OF MEDICINE, 2004, 117 (08): : 618 - 618
[44] Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy?
Tashkin, Donald P.
Strange, Charlie
[J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 2587 - 2601
[45] Inhaled corticosteroids and chronic obstructive pulmonary disease - New and improved evidence?
Samel, JM
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (04) : 407 - 408
[46] EXACERBATIONS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATED WITH INHALED CORTICOSTEROIDS
Vedia, C.
Morros, R.
Caselles, A.
Rodriguez-Blanco, T.
Peras, H.
Baena, J. M.
Amado, E.
Almeda, J.
Toran, P.
Elorza, J. M.
Rosell, M.
[J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2013, 113 : 33 - 34
[47] Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease and the Risk for Coronary Heart Disease
Lee, J.
Yoon, H.
Shin, J.
Lee, Y.
Ha, E.
[J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
[48] Inhaled corticosteroids versus placebo for stable chronic obstructive pulmonary disease
Yang, Ian A.
Ferry, Olivia R.
Clarke, Melissa S.
Sim, Esther H. A.
Fong, Kwun M.
[J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (03):
[49] Associated Factors of Pneumonia in Individuals with Chronic Obstructive Pulmonary Disease (COPD) Apart from the Use of Inhaled Corticosteroids
Lineros, Rosario
Fernandez-Delgado, Lourdes
Vega-Rioja, Antonio
Chacon, Pedro
Doukkali, Bouchra
Monteseirin, Javier
Ribas-Perez, David
[J]. BIOMEDICINES, 2023, 11 (05)
[50] INHALED STEROIDS AND RISK OF PNEUMONIA IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Angelia, Ferina
Purwantyastuti, Purwantyastuti
Soetikno, Vivian
Amin, Zulkifli
[J]. RESPIROLOGY, 2018, 23 : 241 - 242

← 1 2 3 4 5 →